ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,340,670 | -47.0% | 66,833 | -25.5% | 0.00% | -100.0% |
| Q2 2023 | $2,531,933 | +76.5% | 89,753 | +7.6% | 0.00% | 0.0% |
| Q1 2023 | $1,434,635 | -54.0% | 83,409 | -46.2% | 0.00% | 0.0% |
| Q4 2022 | $3,119,525 | +475.6% | 154,892 | +519.7% | 0.00% | – |
| Q3 2022 | $542,000 | -35.4% | 24,995 | -16.2% | 0.00% | – |
| Q2 2022 | $839,000 | -75.5% | 29,843 | -59.8% | 0.00% | -100.0% |
| Q1 2022 | $3,426,000 | +14.8% | 74,255 | +109.1% | 0.00% | 0.0% |
| Q4 2021 | $2,984,000 | +16477.8% | 35,506 | +13298.5% | 0.00% | – |
| Q3 2021 | $18,000 | +28.6% | 265 | +3.9% | 0.00% | – |
| Q2 2021 | $14,000 | +55.6% | 255 | +40.1% | 0.00% | – |
| Q4 2020 | $9,000 | -25.0% | 182 | -29.2% | 0.00% | – |
| Q2 2020 | $12,000 | – | 257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |